Pharma Stocks Decline in Asia After New Trump Tariffs

1. Trump announced a 100% tariff on patented pharmaceuticals from October 1, 2025. 2. Asian pharmaceutical stocks fell in response, led by significant declines. 3. China's drug imports to the U.S. were only 4% in 2024, limiting tariff impact. 4. Exemptions for generic drugs may lower effective tariff rates for some companies. 5. Trump's tariffs also include 25% on large trucks and other goods starting same date.